
News|Slideshows|February 21, 2019
Diabetes Drugs and Cardioprotection: 8 Questions on Key Trials
Author(s)Grace Halsey
Find out what you know about which diabetes drugs in which classes show CV protective properties and results of the trials that support their use.
Advertisement
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
New Large-Scale Study Challenges Previous Research on Menopause and Brain Structure
2
Orforglipron Achieves Up to 12% Weight Loss in Obesity Phase 3 Study: Daily Dose
3
Pooled Safety Analysis Supports Elinzanetant for Vasomotor Symptoms Through 52 Weeks
4
Provider Specialty and Type Drive Divergent Prescribing Patterns for Symptoms of Menopause
5